Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Y-mAbs Therapeutics, Inc. (YMAB)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Mar-31-20 | Dec-31-19 | Mar-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 0.8 | | | | | | | |
| Asset turnover | 0.2 | 0.1 | 0.1 | 0.0 | | 0.0 | 0.0 | |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -743.6% | -2495.9% | -1089.7% | -1987.2% | | -14503.1% | | |
| ROIC (including intangibles) | -430.1% | -3322.6% | -974.1% | -1383.2% | -751.3% | -1837.2% | 1095.4% | 976.3% |
| ROE | -29.7% | -113.3% | -15.3% | -41.7% | -12.9% | -30.8% | -23.4% | -141.3% |
| ROA | -25.1% | -90.8% | -13.8% | -38.4% | -11.6% | -28.5% | -20.9% | -98.7% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 80.7 | 0.0 | 0.0 | | 0.0 | | | 0.0 |
| Days payables outstanding | 2,146.9 | 1,552.8 | 140.0 | | 132.7 | | | 47.7 |
| Days inventory outstanding | 873.2 | | | | | | | |
| Cash conversion cycle | -1,193.0 | -1,552.8 | -140.0 | | -132.7 | | | -47.7 |
|